pain
Health follies of last century
A look back at some of the ‘health misadventures’ common in the earlier years of the 20th century, by Ralph Tapping Health follies’ of the last century might otherwise be …
Pain: the new paradigm
Has pharmacy moved on from the codeine upscheduling? Our panel talks about the new paradigm in pain management by pharmacists In the second of our podcasts on pain treatment and …
The question of pain
In the first of a two-part series, Carlene McMaugh talks to a range of pharmacy experts about pain management. In particular we look at the impact of scheduling changes – …
Chronic pain trial ‘strategically important’
The Guild is encouraging pharmacists to increase patient recruitment numbers for the Chronic Pain MedsCheck Trial In this week’s edition of Forefront, the Guild reminded participating pharmacists that patient recruitment …
Research Roundup
Debbie Rigby rounds up the latest in research news Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease A systematic review and meta-analysis has shown non–vitamin K oral …
A lot of pain
Pharmacy still leads supermarkets as the preferred source of pain medication, with one in seven choosing CWH New data has revealed that pharmacy is still the primary source of pain …
A difficult balance
Dealing with children’s pain is complex and not just a matter of assessing and treating them like a small adult When it comes to children’s pain management, the accurate assessment of …
Back pain for one in four
Back pain is likely to be underreported, say US researchers, despite findings that more than a quarter of working adults have some form of lower back pain The researchers say …
Clinical tips: back pain
Ben Basger takes a look at the drug-related consequences of back pain treatment You might be interested to know about the types of people who presented to the accident and …
Research Roundup
Debbie Rigby rounds up the latest in research news Effects of vitamin D supplementation on musculoskeletal health A systematic review and meta-analysis suggests that vitamin D supplementation does not prevent …
Migraine: up to eight months’ headache days a year
Migraine costs sufferers and their families more than $2.2 billion of health systems costs every year A new report has estimated, for the first time, the economic burden caused by …
Research Roundup
Debbie Rigby takes a look at the latest in research news Second-generation antipsychotics in children Second generation antipsychotics such as clozapine, risperidone, olanzapine and quetiapine pose a serious risk to …